15, Apr 2024
Emorphis Technologies Leads Healthcare Innovation at Arab health

Broadlands, VA, April 15, 2024 — Emorphis Technologies, a global leader in software solutions, continues to spearhead healthcare innovation following its prominent presence at various events across the globe.

At Arab Health 2024, held in Dubai, Nilesh Maheshwari, Founder and CEO, of Emorphis Technologies, interacted with various industry leaders to discuss emerging trends in healthcare technology. The company continued its momentum by participating in the renowned HIMSS Global Health Conference & Exhibition in Orlando, Florida, and the ViVE event held in Los Angeles, California. Emorphis Technologies played a pivotal role in shaping the dialogue around technological innovation in healthcare technology at prestigious events.

These gatherings, held in various locations, provided Emorphis Technologies with invaluable opportunities to showcase its cutting-edge solutions and collaborate with industry peers on the future of healthcare.

“At Emorphis Technologies, we are dedicated to driving innovation in healthcare technology,” said Nilesh Maheshwari, Founder and CEO, of Emorphis Technologies. “Our participation at Arab Health, HIMSS, and ViVE events underscores our commitment to pioneering solutions that empower healthcare providers and improve patient outcomes.”

Emorphis Technologies leveraged these events to showcase its expertise in healthcare software development, emphasizing its focus on building tailored solutions that address the unique challenges faced by healthcare organizations and product companies. From EHR and HIE integration, to telemedicine platforms and digital health solutions, Emorphis Technologies offers a comprehensive suite of solutions designed to enhance clinical workflows, improve patient care, and optimize operational efficiency.

15, Apr 2024
HealthONE’s North Suburban Medical Center Welcomes New President

Denver, CO, April 15, 2024 — Thornton, CO — HealthONE’s North Suburban Medical Center is pleased to welcome Ryan Thornton as its new president and CEO. Thornton joins the hospital, the only Level II trauma center in Adams County, from HCA Healthcare’s Continental Division, which includes HealthONE, where he served as their chief nursing executive for the last three years.

During his tenure as the chief nursing executive at HealthONE, his leadership was pivotal in delivering award-winning quality, including being named the number two large health system in the nation by PINC AI™; expanding academic partnerships to further enhance our new graduate pipeline for registered nurses; and leading an effort to create virtual technologies to enhance the delivery of patient care at the bedside.

For more than a decade, Thornton has worked across HealthONE in several of the health systems’ hospitals, including as the chief nursing officer at Swedish Medical Center after starting his career with HealthONE as the associate chief nursing officer at Rose Medical Center. He joined HealthONE after serving in the United States Air Force for over eight years as both an enlisted member and an officer. Thornton separated from the service with several awards and honors as a Captain.

Thornton earned a Bachelor’s of Arts in Kinesiology, a Bachelor of Science in Nursing and a Master of Arts in Physical Education all from the University of Northern Colorado. He also completed his Master of Business Administration at the University of Colorado in 2020.

Thornton and his wife Amanda are Colorado natives and have two children, Daniel and Elyssa. Their entire family has a passion for serving the community. Amanda and their son serve in the nursing profession, while their daughter serves as a member of the United States Air Force.

15, Apr 2024
SilverPlug USA, Helping to Reduce Dental Implant Failures

SilverPlug USA, Helping to Reduce Dental Implant Failures

Boothbay, ME, April 15, 2024 — SilverPlug USA is proud to introduce to the United States the only material in the world Certified for the specific use as a sealant for the screw tunnel of any type of dental implant. Developed in Switzerland, SilverPlug contains Silver Zeolyte, a natural antibacterial that prevents the formation of biofilm and bacteria. Micro-movement of the implant abutment allows diverse bacteria to form inside the implant tunnel different from that of periodontal disease. The clinician and patient will notice no smell when performing implant maintenance, the lack of mucositis and peri-implantitis over the life of the implant. More than 10 years of clinical reporting has been performed in the EU and elsewhere.

15, Apr 2024
Fortis Hospital Gurugram Launches Maitri – a Dedicated Menopause Clinic

Fortis Hospital Gurugram

Gurugram, 15th April 2024: In a pioneering effort to cater to women’s health-related challenges, Fortis Memorial Research Institute, Gurugram today launched a dedicated clinic for the diagnosis and treatment of menopausal healthcare for women. The clinic was inaugurated by Chief Guest Ms Suneeta Mukherjee, Former Health Secretary, Government of India. The clinic will offer various preventive health services such as pap smear tests, mammography, a transvaginal ultrasound, ultrasound of the entire abdomen, gynae consultation, etc. It would be operational on Fridays from 02:00 pm to 04:00 pm.

Most women experience menopause (a life stage marking the end of reproductive years) between the ages of 45 and 52 years as a natural part of biological aging. However, perimenopause – the transitional period can last for years before menopause and up to 1 year after cessation of periods. According to WHO, perimenopausal and postmenopausal symptoms can be disruptive to personal and professional lives, and changes associated with menopause will affect a woman’s health as she ages. Therefore, perimenopausal care plays an important role in the promotion of healthy aging and quality of life.

Speaking at the launch, Prof. Dr Suneeta Mittal, Senior Director and HOD, Obstetrics and Gynaecology, Fortis Memorial Research Institute, Gurugram said, “As per reports, many women in the 40-45 age bracket have started experiencing early menopause and its accompanying symptoms of hot flushes, weight gain, mood swings, irregular bleeding, among others. With women facing a significant burden of various health issues and the launch of this clinic, women can get themselves treated for all health issues, encompassing everything from gynecological health, menopausal health, mental health, diet and weight control, heart, and bone health”

Suneeta Mukherjee, Former Health Secretary, Government of India said “Women make up 50 per cent of the global population, but tend to neglect their own health needs, especially when it comes to menopause. Empowering women starts with addressing their unique needs. Congratulations to Fortis Gurugram for launching a Dedicated Menopause Clinic by filling the crucial gap, by offering specialized preventive care and education, ensuring every woman’s well-being is a priority.”

Mahipal Singh Bhanot, Senior Vice President & Business Head at Fortis Memorial Research Institute, Gurugram said, “We are happy to launch Maitri, Fortis Menopause Clinic, which is a unique step and the need of the hour. The clinic will cater to the needs of the female patients as they transition through this phase with the support of a dedicated multidisciplinary team who are there to guide the patient at every level”

15, Apr 2024
Aster DM Healthcare announces a Large Special Dividend of Rs.118/- per share to its shareholders.

15th April 2024, Bengaluru: The Board of Directors at Aster DM Healthcare Limited (“Company”), one of the largest integrated healthcare providers in India, has announced a Large Special Dividend of Rs.118/- per share on account of the receipt of proceeds from the sale of the GCC business. The special dividend will be paid within 30 (thirty) days from the date of the declaration i.e. April 23, 2024. This event will result in a significant distribution of ~80% of the consideration of USD 907.6 million as a dividend to its shareholders. Despite this large special dividend, the company will still retain INR~1500 Cr from the sale of GCC business in the reserves under its balance sheet.

The Company had recently concluded the separation of its India and GCC businesses, pursuant to which Affinity Holdings Limited (a wholly subsidiary of the Company) received a cash consideration of USD 907.6M.

The Moopen family continues to hold the 41.88% stake in the listed entity. Dr. Azad Moopen will remain the Founder Chairman and Ms. Alisha Moopen will remain a director on the board of the Company. The listed entity will be led by Dr. Nitish Shetty as Chief Executive Officer, who will focus on the growth of the India business, aimed at creating value for its shareholders.

Dr. Azad Moopen,

Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare said, “The current Indian healthcare market looks promising and post segregation now, our efforts will be to dynamically increase our footprint in India. We are making the right investments in our people, innovation, and infrastructure to differentiate ourselves and create long-term value for all our stakeholders. The dividend to be paid is proof of our commitment to all shareholders. As the company progresses, it will continue to prioritize shareholder interests and make decisions in their best interest towards creating sustained long-term value.”

Dr. Nitish Shetty,

Dr. Nitish Shetty, CEO, Aster DM Healthcare, India said, “The last quarter saw us make significant progress in many aspects, demonstrating our execution strength. We aim to balance shareholder returns with future investments for sustained long-term growth. The dividend distribution plan aims to reward shareholders for their long-held trust and investment in the company. Aster DM Healthcare remains committed to transparency and regulatory compliance throughout the process.”

As the Indian entity is now separate from its GCC counterpart, the Company plans to add 1700 beds by FY27 through the organic route and will further look for expansion through the inorganic route as well. Through both greenfield and brownfield opportunities, the company aims to take its total bed tally in India to 6600+ in the next 3 years and scale up its labs and pharmacy business to emerge as the top 3 integrated healthcare providers in India. The plan will encompass a mix of brownfield and greenfield projects, including the upcoming Aster Capital in Trivandrum, and Aster MIMS Kasargod, and adding bed capacity to the existing hospitals. The Company will also be looking at potential markets such as Maharashtra and Uttar Pradesh. The capital allocation for this expansion is in the range of 1000cr.

12, Apr 2024
Groundbreaking QT Breast Imaging Technology

Groundbreaking QT Breast Imaging Technology

El Dorado Hills, CA, April 12, 2024 — True Health Center for Precision Medicine is proud to announce the integration of state-of-the-art QT imaging technology into its renowned breast imaging facility, Qlarity Breast Imaging, located in El Dorado Hills, CA. This pioneering advancement marks a significant leap forward in the field of precision medicine, offering patients unparalleled accuracy and efficacy in breast health diagnostics.

QT imaging technology represents the latest innovation in medical imaging, providing enhanced clarity and precision in the detection and diagnosis of breast cancers. QT offers radiologists and healthcare providers unparalleled insight into breast tissue composition, enabling early detection of potential breast cancer with unprecedented accuracy.

“At True Health Center for Precision Medicine, we are committed to pushing the boundaries of healthcare innovation to provide our patients with the highest standard of care,” said Kristine Burke, MD, Founder and Medical Director of True Health Center for Precision Medicine. “The integration of QT technology into our Qlarity Breast Imaging facility underscores our dedication to leveraging cutting-edge advancements to revolutionize breast health diagnostics.”

The implementation of QT technology at Qlarity Breast Imaging enables local women and surrounding communities to access the most advanced breast imaging services available. With its ability to detect subtle changes in breast tissue composition just months apart, QT facilitates earlier detection of breast cancer, ultimately leading to more effective treatment outcomes and improved patient prognosis.

True Health Center for Precision Medicine invites patients and healthcare providers in the El Dorado Hills area to experience the transformative capabilities of QT imaging technology at Qlarity Breast Imaging. With its unparalleled accuracy and precision, QT represents a significant advancement in the early detection and diagnosis of breast cancers, ultimately improving patient outcomes and advancing the standard of care in breast health.

12, Apr 2024
Awareness Session on World Parkinson’s Day at MGM Healthcare

World Parkinson's Day

Chennai, 12th April 2024 – In commemoration of World Parkinson’s Day, MGM Healthcare, a multi-speciality quaternary care hospital in the heart of Chennai, conducted a highly informative and impactful awareness session aimed at educating the public about Parkinson’s disease. The event was conducted at MGM Healthcare with participation by neurology experts Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare, and Dr.Sreenivas U.M., Consultant, Department of Neurology, MGM Healthcare, along with Ms. Vijayshree, Chief Dietician, Department of Dietetics, MGM Healthcare and Dr. Rajendran AJ, Clinical Lead, Dept of Rehabilitation Medicine, MGM Healthcare to shed light on this disorder and how to cope with it.

Parkinson’s disease affects millions of people worldwide, with a rising incidence in India. Raising awareness about the disease, including its symptoms, mode of diagnosis, and treatment options is crucial. The awareness session was presented by renowned neurologists from MGM Healthcare, who shared insights into the latest advancements in Parkinson’s research, treatment options, and strategies for improving the quality of life for patients.

The awareness session also highlighted the importance of early detection, proper medication adherence, and the role of physical therapy and lifestyle modifications in managing the symptoms of Parkinson’s.

The Welcome address for the Parkinson’s awareness day was delivered by Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare, following which a yoga exercise session was conducted, to help people with Parkinson’s to improve their balance and mobility.

Dr.Sreenivas U.M., Consultant, Department of Neurology, MGM Healthcare, presented a short insight about the Parkinson’s Disease, including recent research and treatment developments. This was followed by a session on Nutrition for Parkinson’s by Ms. Vijayashree, Chief Dietician, Department of Dietetics, MGM Healthcare.

The last session was on Innovative Exercise Methods for Parkinson’s Management by Dr. Rajendran AJ, Clinical Lead, Dept of Rehabilitation Medicine, MGM Healthcare, which

Dr. U.Meenakshisundaram, Director and Senior Consultant, Department of Neurology, MGM Healthcare shared his thoughts on the awareness program: “MGM Healthcare is honoured to contribute towards raising awareness about this challenging neurological condition. Through our awareness session, we aim to empower the patients with knowledge and support about Parkinsons. We believe that together, we can make a difference in the lives of those affected by Parkinson’s disease.”

As part of its ongoing commitment to neurological care, MGM Healthcare plans to continue organizing educational initiatives and support programs for patients affected by Parkinson’s disease.

11, Apr 2024
T-Medical Group Inc.’s Subsidiary 365Telamind

New York, NY, April 11, 2024 — T-Medical Group Inc., a pioneering force in the healthcare solutions industry, today announced that its wholly-owned subsidiary, 365Telamind, is set to sponsor an exclusive women’s mental health empowerment event on April 28, 2024, from 3 pm to 7 pm in Westbury, New York. This groundbreaking initiative aims to foster a deeper understanding of the unique mental health challenges faced by women while inspiring them to embrace their inherent strengths and unleash their full potential.

At the core of this transformative event lies a profound belief in the power of open dialogue and the promotion of mental well-being among women from all walks of life. In line with this vision, the event will feature renowned speakers and thought leaders who will delve into the multifaceted aspects of women’s mental health, underscoring the critical need for compassionate understanding and robust support systems within our communities.

Headlining the event will be Dr. Lena G. Clark, the esteemed CEO of T-Medical Group Inc., and Quenton “QdaBoss” Brown, the event organizer and founder of Empowered Dynasty a highly acclaimed motivational speaker and mental health advocate. These exceptional figures will share their invaluable insights, inspiring attendees to embrace self-acceptance, resilience, and the pursuit of personal growth.

“As a society, we must actively work towards supporting and lifting up one another, particularly when it comes to mental health matters,” Dr. Lena G. Clark passionately expressed. “By facilitating open discussions and providing valuable resources, we can cultivate an atmosphere of inclusivity wherein every woman feels seen, heard, and appreciated.”

Attendees of the event can expect an immersive and transformative experience that transcends traditional lectures. They will have the unique opportunity to interact with experts, connect with fellow participants who share a passion for mental health advocacy, and partake in thought-provoking activities designed to ignite personal growth and foster lasting change.

“We are thrilled to host this groundbreaking event and contribute to the ongoing conversation surrounding women’s mental health,” said Dr. Lena G. Clark, CEO of T-Medical Group, Inc. “By bringing together influential voices and creating a safe space for dialogue, we aim to empower women to embrace their authentic selves and forge a path towards collective healing and empowerment.”

This exclusive event promises to be a catalyst for positive change, igniting a movement that celebrates the resilience and strength of women while promoting mental well-being as a fundamental human right. Don’t miss this extraordinary opportunity to learn, grow, and forge meaningful connections with those who share your dedication to enhancing women’s mental health. Mark your calendars for April 28, 2024, and join them in shaping a brighter future for all.

11, Apr 2024
Boiron’s Wellness Kits Offer Holistic Approach to Pain Management

Newtown Square, PA, April 11, 2024 –Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and symptoms of stress.

“Pain can often lead to frequent nighttime awakenings, disrupting sleep patterns and causing discomfort,” said Ken Redcross, a board-certified internal medicine physician. He said research indicates those who experience poor or insufficient sleep are more likely to report higher levels of pain sensitivity, creating a challenging cycle that hampers well-being. Additionally, stress can also heighten the perception of pain and contribute to sleeplessness.

“Many individuals actively search for solutions to address pain, sleep, and stress symptoms which are all interconnected so they can better manage their pain which enhances their overall well-being,” Dr. Redcross said.

“I always advise my patients to consider ‘closer to the earth’ remedies, such as homeopathic medicines, which carry a very low risk of side effects and can be safely used alongside other treatments,” he continued, noting that many people may resort to taking multiple medications when addressing these concerns.

Included in the kits is Arnicare Cream, formulated with Arnica to relieve muscle pain and stiffness, swelling from injuries, and bruises.* To complement the cream, the kits contain either melatonin-free SleepCalm® Meltaway Tablets for night use or StressCalm® Meltaway Tablets for daytime. SleepCalm offers a non-habit forming solution to relieve occasional sleeplessness, restless sleep, and intermittent awakening.* For daytime use, StressCalm provides non-drowsy relief for occasional nervous tension, irritability, hypersensitivity, and fatigue due to everyday stress.*

11, Apr 2024
Ombra Group Acquires 75% of IUT Medical GmbH

New York, NY, April 11, 2024 –Ombra Group Inc, a global pioneer in advanced technology solutions, today announced its acquisition of IUT Medical GmbH, a world-renowned German company specializing in cutting-edge gas and hazardous chemical detection systems. Founded in 1998 by the late Prof. Dr. Jürgen Leonhardt, IUT Medical has solidified its reputation as an industry leader, delivering unparalleled accuracy and reliability to clients across the globe.

This strategic move underscores Ombra Group’s commitment to the rapidly evolving environmental and industrial safety market, forecasted to reach a staggering US $60 billion by 2030, according to a comprehensive report by MarketsandMarkets Research. A key driver behind the acquisition is Ombra Group’s ambition to harness IUT Medical’s pioneering breath analysis technology for detecting controlled substances such as fentanyl, methamphetamine, and tetrahydrocannabinol (THC). Additionally, the combined entity aims to empower law enforcement agencies worldwide with advanced solutions for identifying and dismantling clandestine drug production facilities.

By integrating IUT Medical’s decades of expertise in gas and chemical detection with Ombra Group’s cutting-edge artificial intelligence (AI) and software engineering capabilities, the two companies are poised to usher in a new era of innovation within the public health and safety sector. This powerful synergy will catalyze the development of next-generation detection solutions that are not only more intelligent and efficient but also unprecedented in their accuracy and reliability.

“Acquiring IUT Medical is a strategic move that will propel our future product development initiatives to new heights,” said Dominick Bianco, CEO of Ombra Group. “Their superior detection technology, coupled with our proficiency in AI and software, creates a formidable foundation for introducing ultra-intelligent solutions that will redefine industry standards. We are excited to combine our respective strengths and unlock the full potential of IUT Medical’s groundbreaking systems.”

The acquisition promises to yield significant benefits for both companies and their respective customers:

Heightened Product Value: By seamlessly integrating Ombra Group’s AI and software capabilities into IUT Medical’s existing suite of detection systems, the combined entity will deliver smarter, more efficient, and highly competitive solutions that cater to the evolving needs of the market.

Accelerated Technological Advancements: The collective knowledge, resources, and expertise of these two industry leaders will fuel the rapid development of novel, high-tech gas and chemical detection devices, solidifying their position at the forefront of innovation.

Enhanced Operational Efficiencies: By streamlining operations and leveraging shared resources, the combined entity will benefit from increased operational efficiencies, enabling faster time-to-market for new products and solutions.

Expanded Global Reach: Leveraging Ombra Group’s management and extensive global footprint, IUT Medical’s cutting-edge products will gain access to new markets and customer segments across diverse environmental and industrial safety domains.

“This acquisition marks a significant milestone for IUT Medical and a testament to Prof. Leonhardt’s enduring legacy,” stated Franz Finsch, spokesperson for IUT Medical. “Joining forces with Ombra Group ensures the continued growth and evolution of our cutting-edge detection technologies, while providing us with the resources and expertise to tackle some of the most pressing challenges in the realms of illegal drug production and use. We are excited to embark on this new chapter and seize the myriad opportunities that lie ahead in the rapidly expanding gas and chemical detection market.”